Shanghai Xuerong Biotechnology Co.,Ltd.

SZSE:300511 Stock Report

Market Cap: CN¥1.8b

Shanghai Xuerong BiotechnologyLtd Management

Management criteria checks 2/4

Shanghai Xuerong BiotechnologyLtd's CEO is Yongping Yang, appointed in Apr 2022, has a tenure of 2.67 years. directly owns 21.57% of the company’s shares, worth CN¥383.08M. The average tenure of the management team and the board of directors is 2.7 years and 2 years respectively.

Key information

Yongping Yang

Chief executive officer

CN¥1.0m

Total compensation

CEO salary percentagen/a
CEO tenure2.7yrs
CEO ownership21.6%
Management average tenure2.7yrs
Board average tenure2yrs

Recent management updates

Recent updates

Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Shares Fly 48% But Investors Aren't Buying For Growth

Oct 08
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Shares Fly 48% But Investors Aren't Buying For Growth

Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Price Is Right But Growth Is Lacking After Shares Rocket 45%

Aug 19
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Price Is Right But Growth Is Lacking After Shares Rocket 45%

Little Excitement Around Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Revenues As Shares Take 31% Pounding

Jun 27
Little Excitement Around Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Revenues As Shares Take 31% Pounding

There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise

May 13
There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise

Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry

Mar 15
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry

CEO

Yongping Yang (55 yo)

2.7yrs

Tenure

CN¥1,026,600

Compensation

Mr. Yongping Yang serves as Chairman of Shanghai Xuerong Bio-Technology Co., Ltd. and serves as its General Manager since April 12, 2022. Mr. Yang serves as Honorary President of Fujian Chamber of Commerce...

Leadership Team

NamePositionTenureCompensationOwnership
Yongping Yang
Chairman & GM2.7yrsCN¥1.03m21.57%
CN¥ 383.1m
Yong Lu
Deputy GM & Non-Independent Directorno dataCN¥845.30kno data
Wei Guo
Deputy GM & Non-Independent Director2.7yrsCN¥1.01m0.012%
CN¥ 213.6k
Yongkang Gu
Board Secretary6yrsCN¥717.00k0.0059%
CN¥ 104.1k

2.7yrs

Average Tenure

48.5yo

Average Age

Experienced Management: 300511's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yongping Yang
Chairman & GMno dataCN¥1.03m21.57%
CN¥ 383.1m
Yong Lu
Deputy GM & Non-Independent Director2.6yrsCN¥845.30kno data
Wei Guo
Deputy GM & Non-Independent Director2yrsCN¥1.01m0.012%
CN¥ 213.6k
Lihua Mao
Non-Employee Supervisor7.3yrsno datano data
Jianchun Huang
Independent Director4.1yrsCN¥120.00kno data
Jie Li
Director1.8yrsCN¥773.50k0.0096%
CN¥ 170.8k
Xueyao Li
Independent Director1.6yrsCN¥120.00kno data
Danmeng Li
Independent Director1.3yrsCN¥42.60kno data

2.0yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 300511's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 08:29
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Xuerong Biotechnology Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jia ChenChangjiang Securities Co. LTD.
You You LiuChina Stock Investment Research Co. Ltd. (GZ500..com)
Xiao Bao LiuEverbright Securities Co. Ltd.